Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Aceso Life Science Group Limited ( (HK:0474) ).
Aceso Life Science Group Limited announced the completion of a deemed disposal transaction following the placement of new shares by its non-wholly-owned subsidiary, HTICI. This transaction resulted in the dilution of Aceso’s shareholding in HTICI from 29.05% to 28.58%, leading to HTICI no longer being a subsidiary. Consequently, HTICI’s results will not be consolidated in Aceso’s financial statements but will be accounted for as an interest in an associate, allowing Aceso to continue benefiting from HTICI’s net assets and operating results.
More about Aceso Life Science Group Limited
Aceso Life Science Group Limited is a company incorporated in the Cayman Islands, operating within the life sciences industry. It focuses on the development and management of life science-related products and services.
Average Trading Volume: 529,101
Technical Sentiment Signal: Sell
Current Market Cap: HK$177.2M
For an in-depth examination of 0474 stock, go to TipRanks’ Stock Analysis page.